Albany, NY -- (SBWIRE) -- 05/17/2016 -- Description

About Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis belongs to a group of lung diseases known as interstitial lung diseases. It affects people in the age group 50-70 years. Diagnosis is effected by the exclusion of other interstitial lung diseases. High-resolution computed tomography (CT) is often employed to confirm the presence of the disease. There is no permanent cure for this disease; therefore, treatment involves relieving underlying symptoms. Nintedanib and pirfenidone are the two approved drugs for the treatment of idiopathic pulmonary fibrosis. Corticosteroids and immunosuppressive drugs are also used for the treatment.

Technavios analysts forecast the Global Idiopathic Pulmonary Fibrosis Market to grow at a CAGR of 23.97% during the period 2016-2020.

View Full Report at: http://www.marketresearchreports.biz/analysis/717645

Covered in this report

The report covers the present scenario and the growth prospects of the global idiopathic pulmonary fibrosis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of idiopathic pulmonary fibrosis.

The market is divided into the following segments based on geography:

Americas
APAC
EMEA

Technavio's report, Global Idiopathic Pulmonary Fibrosis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/analysis/717645

Key vendors
Baxter International
Boehringer Ingelheim
F.Hoffmann-La Roche
Prometheus Laboratories

Other prominent vendors
Afferent Pharmaceuticals
Amgen
Biogen
Bristol-Myers Squibb
Cipla
FibroGen
Gilead Sciences
GlaxoSmithKline
GNI Group
Horizon Pharma
ImmuneWorks
MediciNova
MedImmune (subsidiary of AstraZeneca)
Novartis
Pfizer
Promedior
ProMetic Life Sciences
Sanofi
Shionogi
Zai Lab

Market driver
Unmet medical need
For a full, detailed list, view our report

Market challenge
Lack of proper diagnosis
For a full, detailed list, view our report

Market trend
Patient assistance programs
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Browse all latest Press Releases of Market Research Reports at: http://www.marketresearchreports.biz/pressreleases

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
Mr. Nachiket
90 Sate Street,
Suite 700 Albany,
NY 12207 USA
Tel: +1-518-621-2074
Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz